Digital health-startup Alodokter raises $9mn in Series B funding

By Catherine Sturman
Led by SoftBank Ventures Korea, digital health start-up company Alodokter has raised $9mn in Series B funding. The investment will see the company devel...

Led by SoftBank Ventures Korea, digital health start-up company Alodokter has raised $9mn in Series B funding. The investment will see the company develop and integrate its app technology to further provide exceptional patient support across the platform. Golden Gate Ventures and Feng also participated in the funding round.

Established in 2014, patients can access their data through the mobile app and have the ability to book appointments and be the ‘go-to’ app for individuals who have a healthcare issue access medical services through one core platform, providing an essential solution for its 16 million active users.  

Recently, the company has installed a chat feature on the app, which utilises artificial intelligence and enables its users to chat with medical professionals at a time convenient for them.

Related stories

“We believe that a mix of AI and real-doctor interaction is the future of healthcare online,” explained CEO Nathanael Faibis. We are gathering one of the largest databases of patient/doctor interaction, which will give us an important edge in providing one of the best digital healthcare services.”

“We want our app to become top of mind for patients when they have a medical issue,” he added.

“By managing so much information about patients, doctors and service providers, we are gradually building a much more efficient solution than traditional methods to find the right solution for patients.”

Supporting over 250,000 patients a month, the company aims to further expand its service offering and enter further markets, but is going to meet stiff competition with competitors, such as MeetDoctor and 1Health.

Share

Featured Articles

WHO Health Chatbot Built on 'Humanised' GenAI

World Health Organisation's GenAI digital health tool is built using ‘AI humanisation’ tech & designed to ease burden on health workers & educate on health

Costco Weight-Loss Drugs Move Highlights US AOM Growth

Costco move to partner with online healthcare provider Sesame to provide members with weight-loss drugs including Wegovy signals US anti-obesity boom

AstraZeneca Company Profile, as CEO Soriot Lands pay Deal

As it's announced AstraZeneca's CEO Pascal Soriot's package could rise by as much as US$24mn we explore the history of the UK's most valuable business

US Academic Medical Centres 'Struggling' says McKinsey

Hospitals

J&J Community Initiatives Tackle US Healthcare Chasm

Medical Devices & Pharma

PitchBook: Healthcare Private Equity Deals see Decline

Health Insurance & Finance